Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer

Summary

TLK199.2102 was a multicenter Phase 2 randomized study to determine the effect of Telintra treatment on chemotherapy induced neutropenia (CIN) in patients with non small cell lung cancer receiving first-line therapy with carboplatin and docetaxel.

Timeline

Start

2008-10

Primary completion

2008-11

Completion

2008-11

Outcome

Outcome not reported

Stopped (Enrollment): “Study TLK199.2102 was terminated for lack of enrollment.”

Drugs

Indications